Indinavir, Efavirenz, and Abacavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Subjects

Adult AIDS Clinical Trials Group (AACTG) Protocol 886 examined the dispositions of indinavir, efavirenz, and abacavir in human immunodeficiency virus-infected subjects who received indinavir at 1,000 mg every 8 h (q8h) and efavirenz at 600 mg q24h or indinavir at 1,200 mg and efavirenz at 300 mg q12...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: DiCenzo, Robert, Forrest, Alan, Squires, Kathleen E., Hammer, Scott M., Fischl, Margaret A., Wu, Hulin, Cha, Raymond, Morse, Gene D.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2003
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC155818/
https://ncbi.nlm.nih.gov/pubmed/12760869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.6.1929-1935.2003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky